Prostatis Group’s Vanguard Mid-Cap Growth ETF VOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-36,129
Closed -$36.1K 245
2023
Q2
$36.1K Buy
+36,129
New +$7M 0.02% 201
2022
Q1
Sell
-1,111
Closed -$283K 107
2021
Q4
$283K Sell
1,111
-390
-26% -$98.3K 0.17% 79
2021
Q3
$355K Sell
1,501
-49
-3% -$11.9K 0.21% 71
2021
Q2
$366K Sell
1,550
-229
-13% -$51.4K 0.25% 71
2021
Q1
$382K Sell
1,779
-152
-8% -$33K 0.3% 72
2020
Q4
$409K Sell
1,931
-479
-20% -$94.3K 0.34% 56
2020
Q3
$434K Buy
+2,410
New +$425K 0.41% 50

Other funds holding VOT

Prostatis Group's VOT Position: Q3 2023 in Review

Prostatis Group sold out of Vanguard Mid-Cap Growth ETF (VOT) in Q3 2023, closing a stake of 36,129 shares — an estimated $36.1K sold.

Prostatis Group first reported a position in VOT in Q3 2020 and held it in 7 quarters. The position peaked at $434K in Q3 2020. 754 funds tracked by Wall St. Rank hold VOT as of Q3 2023.

  • Prostatis Group reported no remaining Vanguard Mid-Cap Growth ETF position as of Q3 2023 after selling out during the quarter.
  • Prostatis Group sold 36,129 Vanguard Mid-Cap Growth ETF shares in Q3 2023, an estimated $36.1K.
  • Prostatis Group first reported a position in Vanguard Mid-Cap Growth ETF in Q3 2020 and held it in 7 quarters.
  • Prostatis Group's Vanguard Mid-Cap Growth ETF position peaked at $434K in Q3 2020.
  • 754 funds tracked by Wall St. Rank held Vanguard Mid-Cap Growth ETF as of Q3 2023.

Based on Prostatis Group's 13F filing for Q3 2023, filed 21 Mar 2025.